Clinuvel Pharmaceuticals Ltd
XBER:UR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Clinuvel Pharmaceuticals Ltd
XBER:UR9
|
AU |
|
Autobacs Seven Co Ltd
F:AB6
|
JP |
|
R
|
Rewalk Robotics Ltd
SWB:2RW
|
IL |
|
M
|
Macerich Co
F:M6G
|
US |
|
V
|
Ventas Inc
F:VEN
|
US |
|
I
|
Italian Sea Group SpA
F:6QN
|
IT |
|
Minerva Neurosciences Inc
F:4MNA
|
US |
|
B
|
Bayer AG
F:BAYA
|
DE |
|
Petrofac Ltd
F:P2F0
|
JE |
|
Dai Nippon Printing Co Ltd
F:DNP0
|
JP |
|
Target Hospitality Corp
NASDAQ:TH
|
US |
|
C
|
Carnival PLC
F:POH1
|
UK |
|
S
|
Seabridge Gold Inc
F:SRM
|
CA |
|
C
|
Chalice Mining Ltd
SWB:C8U
|
AU |
|
C
|
Champion Iron Ltd
F:MMPI
|
AU |
|
C
|
Cognex Corp
F:CGZ
|
US |
|
Jollibee Foods Corp
OTC:JBFCF
|
PH |
|
C
|
Canadian Natural Resources Ltd
XMUN:CRC
|
CA |
|
C
|
Clinuvel Pharmaceuticals Ltd
XMUN:UR9
|
AU |
|
J
|
Japan Post Bank Co Ltd
SWB:5JP
|
JP |
|
V
|
Viatris Inc
DUS:VIA
|
US |
|
P
|
Petrofac Ltd
F:P2F
|
JE |
|
V
|
voestalpine AG
DUS:VAS
|
AT |
|
Chalice Mining Ltd
ASX:CHN
|
AU |
Wall St Price Targets
UR9 Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for UR9 is 16.66 EUR with a low forecast of 8.91 EUR and a high forecast of 27.94 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UR9's stock price target?
Price Target
16.66
EUR
According to Wall Street analysts, the average 1-year price target for UR9 is 16.66 EUR with a low forecast of 8.91 EUR and a high forecast of 27.94 EUR.
What is the Revenue forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Net Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
10%
The compound annual growth rate for Net Income over the next 8 years is 10%.
